期刊文献+

含绿色荧光蛋白和hytk双顺反子真核表达载体的构建及其在膀胱癌细胞中的表达 被引量:2

The construction of bicistronic eukaryotic vector carrying green fluorescent protein and hytk gene and its expression in bladder carcinoma
下载PDF
导出
摘要 目的 :构建一种带有绿色荧光蛋白 (gfp)、潮霉素磷酸转移酶和HSV -tk的融合基因cDNA(hytk)的新型真核表达载体。方法 :利用脑炎心肌炎病毒 (EMCV)的内部核糖体进入位点 (IRES) ,将gfp的cDNA与hytk基因连接 ,构建获得含gfp和hytk基因的重组质粒 ;lipofectin介导下转染人膀胱癌细胞株EJ,并检测其表达情况。结果 :成功地构建了含gfp和hytk基因双顺反子真核表达载体 ,PCR检测证实转基因细胞的gfp与hytk基因的整合 ,荧光显微镜下可观察到发绿色荧光的转基因细胞 ,MTT法测定示丙氧鸟苷 (GCV)对EJ/hytk -gfp细胞有明显的杀伤作用 ,此杀伤效应呈时间和剂量依赖性 ,72hIC5 0值为 2 16mg/L ,而对野生型的EJ细胞无明显毒性 (P <0 0 5 )。结论 AIM: To facilitate the suicide gene delivery into neoplasm, a chimeric gene of HSV-tk and green fluorescent protein (gfp) was constructed. METHODS: Molecular cloning technique was used to construct this kind of eukaryotic vector. The internal ribosome entry site (IRES) of encephalomyocarditis virus (EMCV), which could coordinate expression of two genes in a single vector, was optioned. By using liposome-mediated transfection, eukaryotic expression vector tgCMV/hytk-IRES-gfp was transfected into human bladder carcinoma cells EJ. RESULTS: A bicistronic eukaryotic vector carrying gfp and hygromycin phosphotransferase-thymidine kinase fusion (hytk) gene was constructed. The results of PCR and microscopy detection show that the hytk-IRES-gfp gene was successfully transferred into EJ cells. There were no differences in the growth pattern or the morphology between EJ and EJ/hytk-GFP cells. In vitro experiments demonstrated dose- and time-dependent cell killing by transduction of the hytk-IRES-gfp gene followed by GCV treatment. The IC50 (the concentration required to elicit 50% growth inhibition) was 2.16 mg/L in treatment with GCV for 72 hours. CONCLUSION: These results suggest that this new kind of eukaryotic vector could serves as a new tool and method for neoplasm gene therapy.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2001年第9期825-829,共5页 Chinese Journal of Pathophysiology
基金 福建省科委科研基金资助 (No .99-Z - 16 7)
关键词 绿色荧光蛋白 核糖体 膀胱肿瘤 癌细胞 基因表达 肿瘤基因治疗 基因转移 Fluorescence Genes Ribosome Bladder neoplasms
  • 相关文献

参考文献4

二级参考文献3

  • 1金冬雁,分子克隆实验指南(第2版),1992年,24页
  • 2Kwong Y L,Current Protocols in Human Genetics Copyrinhto 1997,1997年,1355页
  • 3Sheng Y,Nucleic Acids Res,1995年,23卷,1990页

共引文献16

同被引文献15

  • 1胡志远,邢桂春,贺福初.用脂质体法转染 COS-7 细胞条件的优化[J].军事医学科学院院刊,1997,21(2):125-127. 被引量:10
  • 2Hockney RC.Recent developments in heterologous protein production in Escherichia coli[J].Trends Biotechnol,1994,12:456-463.
  • 3Groopman JE;Molina JM,Scadden DT.Hematopoietic growth factors.Biology and clinical applications[J].N Engl J Med,1989,321:1449-1459.
  • 4Misener S,Kraweta SA.Bioinformatics methods and protocols[M].New Jersey:Human Press Inc.,2000:112-143.
  • 5Israeli RS,Powell CT,Fair WR,et al.Molecular cloning of a complementary DNA encoding a prostate-spscific membrane antigen[J].Cancer Res,1993,53:227-230.
  • 6奥斯伯 F 著.精编分子生物学实验指南[M].颜子颖,王海林译.北京:北京科学出版社,1998:983-992.
  • 7Tjoa BA,Simmons SJ,Elgamal A,et al.Follow-up evaluation of a phase Ⅱ prostate cancer vaccine trial[J].Prostate,1999,40:125-129.
  • 8Dranoff G,Jaffee E,Lazenby A,et al.Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent,specific,and long-lasting anti-tumor immunity[J].Proc Natl Acad Sci USA,1993,90:3539-3543.
  • 9Johnen H,Kulbe H,Pecher G.Long-term tumor growth suppression in mice immunized with naked DNA of the human tumor antigen mucin (MUC1)[J].Cancer Immunol Immunother,2001,50:356-360.
  • 10Dummer R.GVAX(Cell Genesys)[J].Curr Opin Investig Drugs,2001,2:844-848.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部